Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Surges 12% In a Week: Here is Why
The past week has been quite fruitful for investors in Northwest Biotherapeutics (OTCMKTS:NWBO) as the company’s stock went on a steady rally and clocked gains of 12% during the period. The company is currently best known for working on the development of DCVax, which is a customized immune therapy meant for tackling solid cancer tumors. Trading Data On Friday, NWBO stock increased 1.69% to $0.7840 with 2.82 million shares, compared…